Kevin Cureton - 17 May 2023 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (SLSN)

Signature
/s/ Jess Jankowski under UPA for Kevin Cureton
Issuer symbol
SLSN
Transactions as of
17 May 2023
Net transactions value
+$55,392
Form type
4
Filing time
05 Jun 2023, 20:02:57 UTC
Previous filing
22 Dec 2022
Next filing
29 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NANX Common Stock Purchase $920 +1,000 +2% $0.9200 51,821 17 May 2023 Direct
transaction NANX Common Stock Purchase $16,214 +15,590 +30% $1.04 67,411 18 May 2023 Direct
transaction NANX Common Stock Purchase $10,400 +10,000 +15% $1.04 77,411 19 May 2023 Direct
transaction NANX Common Stock Purchase $27,858 +23,410 +30% $1.19 100,821 26 May 2023 Direct
holding NANX Common Stock 50,821 17 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NANX Common Stock (right to purchase) 25,000 17 May 2023 Common Stock 25,000 $0.5200 Direct F1, F2
holding NANX Common Stock (right to purchase) 50,000 17 May 2023 Common Stock 50,000 $0.4400 Direct F1
holding NANX Common Stock (right to purchase) 43,500 17 May 2023 Common Stock 43,500 $0.4200 Direct F1
holding NANX Common Stock (right to purchase) 50,000 17 May 2023 Common Stock 50,000 $0.6800 Direct F1
holding NANX Common Stock (right to purchase) 80,000 17 May 2023 Common Stock 80,000 $0.8200 Direct F1
holding NANX Common Stock (right to purchase) 16,500 17 May 2023 Common Stock 16,500 $0.5100 Direct F1
holding NANX Common Stock (right to purchase) 90,000 17 May 2023 Common Stock 90,000 $0.4500 Direct F1
holding NANX Common Stock (right to purchase) 90,000 17 May 2023 Common Stock 90,000 $4.17 Direct F1
holding NANX Common Stock (right to purchase) 72,000 17 May 2023 Common Stock 72,000 $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
F2 Following the recently reported exercise of 12,393 shares (11/24/21), and the 2nd exercise of 12,607 shares (11/26/21, reported above) this line item represents the 3rd exercise, of 25,000 shares of the total initial grant of 75,000 shares, leaving a balance of 25,000 shares remaining relating to this grant.